Auhtors: Xie Chaohui, Hao Xianghui, Yang Lingling, Xu Haifeng DOI: 10.3760/cma.j.cn115989-20210407-00234 Published 2022-06-10 Cite asChin J Exp Ophthalmol, 2022, 40(6): 507-513. Abstract [View PDF] [Read Full Text] Objective To observe the influence of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) 4 […]
Tag: Bevacizumab
Inhibitory effects of bevacizumab on filtering bleb scarring following trabeculectomy in rabbits
Authors: Liang Pei, Yang Jin, Lin Jinyong DOI: 10.3760/cma.j.issn.2095-0160.2016.07.004 Published 2016-07-10 Cite as Chin J Exp Ophthalmol, 2016,34(7): 591-596. Abstract [Download PDF] [Read Full Text] Background The primary reason to trabeculectomy failure is fibrosis of conjunctiva and episclera because of progressive fibroblast proliferation and collagen deposition […]
Research progress of Ahmed glaucoma valve implantation in the treatment of neovascular glaucoma
Authors: Hou Yanhong, Cui Hongping DOI: 10.3760/cma.j.issn.2095-0160.2017.04.016 Published 2017-04-10 Cite as Chin J Exp Ophthalmol, 2017,35(4): 368-371. Abstract [Download PDF] [Read Full Text] Neovascular glaucoma (NVG) is a kind of devastating secondary glaucoma characterized by neovascularization in iris and anterior chamber angle, which often results in loss […]
Inhibitory effects of bevacizumab on corneal neovascularization and scarring in mice with herpes simplex keratitis
Authors: Zhou Hongwei, Wang Tongsong, Zhang Songmei, Xie Lixin DOI: 10.3760/cma.j.issn.2095-0160.2017.12.007 Published 2017-12-10 Cite as Chin J Exp Ophthalmol, 2017,35(12): 1085-1091. Abstract [Download PDF] [Read Full Text] Background Corneal neovascularization and inflammation occur in herpes simplex keratitis (HSK). Aciclovir (ACV) is an antiviral medication which is primarily used for […]
Recent advances of bevacizumab as an adjunct to trabeculectomy
Authors: Chen Juan, Yu Wenzhen DOI: 10.3760/cma.j.issn.2095-0160.2018.08.015 Published 2018-08-10 Cite as Chin J Exp Ophthalmol, 2018,36(8): 649-652. Abstract [Download PDF] [Read Full Text] Glaucoma is a group of diseases characterized by progressive optic nerve damage and characteristic visual field defect.Increased intraocular pressure is the main risk factor […]
Problems and challenges of anti-vascular endothelial growth factor therapy for ocular neovescularization diseases
Authors: Chen Youxin, Tang Jia DOI: 10.3760/cma.j.issn.2095-0160.2019.01.001 Published 2019-01-10 Cite as Chin J Exp Ophthalmol, 2019,37(1): 1-4. Abstract [Download PDF] [Read Full Text] Anti-vascular endothelial growth factor (VEGF) therapy is a major strategy for treating ocular neovascular diseases nowadays.It has revolutionarily improved the […]